Woodline Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.8M | Buy |
1,019,979
+194,621
| +24% | +$15.2M | 0.42% | 41 |
|
|
2025
Q1 | $59.8M | Buy |
825,358
+814,917
| +7,805% | +$59.1M | 0.39% | 59 |
|
|
2024
Q4 | $773K | Sell |
10,441
-342,796
| -97% | -$25.4M | 0.01% | 791 |
|
|
2024
Q3 | $23.3M | Buy |
353,237
+87,159
| +33% | +$5.75M | 0.2% | 169 |
|
|
2024
Q2 | $24.6M | Sell |
266,078
-215,848
| -45% | -$19.9M | 0.23% | 136 |
|
|
2024
Q1 | $46.1M | Buy |
481,926
+180,214
| +60% | +$17.2M | 0.42% | 64 |
|
|
2023
Q4 | $23M | Buy |
+301,712
| New | +$23M | 0.25% | 123 |
|
|
2023
Q3 | – | Sell |
-578,141
| Closed | -$54.5M | – | 633 |
|
|
2023
Q2 | $54.5M | Buy |
578,141
+368,892
| +176% | +$34.8M | 0.65% | 38 |
|
|
2023
Q1 | $17.3M | Buy |
209,249
+160,931
| +333% | +$13.3M | 0.24% | 120 |
|
|
2022
Q4 | $3.61M | Sell |
48,318
-379,569
| -89% | -$28.3M | 0.05% | 369 |
|
|
2022
Q3 | $35.4M | Buy |
+427,887
| New | +$35.4M | 0.49% | 41 |
|
|
2022
Q2 | – | Sell |
-283,730
| Closed | -$33.4M | – | 823 |
|
|
2022
Q1 | $33.4M | Buy |
+283,730
| New | +$33.4M | 0.54% | 47 |
|
|
2021
Q3 | – | Sell |
-307,190
| Closed | -$31.8M | – | 701 |
|
|
2021
Q2 | $31.8M | Buy |
+307,190
| New | +$31.8M | 0.59% | 42 |
|
|
2020
Q2 | – | Sell |
-172,383
| Closed | -$10.8M | – | 162 |
|
|
2020
Q1 | $10.8M | Buy |
+172,383
| New | +$10.8M | 0.77% | 40 |
|